Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: Int J Cancer. 2016 Feb 8;138(10):2346–2356. doi: 10.1002/ijc.29968

Table 1.

Tumor characteristics at diagnosis according to breast cancer phenotypes in the Nurses' Health Studies

Luminal A Luminal B HER2-enriched Basal-like Unclassified

N (%) 2063 (54.8) 1008 (26.8) 209 (5.6) 378 (10.0) 110 (2.9)
Mean age at diagnosis, years 56.9 58.3 57.7 54.1 54.4
Median age at diagnosis, years 56.9 58.2 57.2 53.3 54.8
Tumor size, N (%)a,c
 0.1 to 1.0 cm 535 (26.9) 223 (23.8) 34 (17.0) 47 (13.1) 20 (19.8)
 1.1 to less than 2.0 cm 816 (41.1) 402 (41.1) 56 (28.0) 120 (33.4) 36 (35.6)
 2.0 to less than 4 cm 449 (22.6) 269 (27.5) 85 (42.5) 165 (46.0) 30 (29.7)
 >4+ cm 186 (9.4) 74 (7.6) 25 (12.5) 27 (7.5) 15 (14.9)
 Missing 77 30 9 19 9
Nodal involvement, N (%)a,c
 No nodes 1276 (65.9) 601 (64.3) 103 (51.8) 218 (61.4) 59 (59.6)
 1–3 nodes 398 (20.6) 204 (21.8) 48 (24.1) 90 (25.4) 14 (14.1)
 4–9 nodes 153 (7.9) 84 (9.0) 25 (12.6) 32 (9.0) 11 (11.1)
 10+ nodes/metastatic 110 (5.7) 46 (4.9) 23 (11.6) 15 (4.2) 15 (15.2)
 Missing 126 73 10 23 11
Stage, N (%)a,c
 Stage I/II 1572 (83.9) 768 (83.9) 137 (71.4) 289 (85.0) 68 (72.3)
 Stage III/IV 302 (16.1) 147 (16.1) 55 (28.7) 51 (15.0) 26 (27.7)
 Missing 189 93 17 38 16
Grade, N (%)b,c
 Well-differentiated 580 (28.2) 148 (14.8) 4 (2.0) 7 (1.9) 17 (15.5)
 Intermediate differentiated 1328 (64.7) 522 (52.4) 96 (47.1) 97 (25.8) 43 (39.1)
 Poorly differentiated 146 (7.1) 327 (32.8) 104 (51.0) 272 (72.3) 50 (45.5)
 Missing 9 11 5 2 0
Histologic type, N (%)a,c
 Invasive ductal 1637 (79.9) 863 (85.6) 203 (97.1) 351 (95.4) 95 (88.8)
 Invasive lobular 291 (14.2) 83 (8.3) 2 (1.0) 4 (1.1) 7 (6.5)
 Invasive ductal/lobular 109 (5.3) 42 (4.2) 0 (0.0) 2 (0.5) 2 (1.9)
 Invasive NOS 13 (0.6) 9 (0.9) 2 (1.0) 11 (3.0) 3 (2.8)
 Missing 13 11 2 10 3
Race, N (%)
 White 1965 (95.3) 950 (94.3) 203 (97.1) 349 (92.3) 106 (96.4)
 Black 23 (1.1) 7 (0.7) 1 (0.5) 13 (3.4) 1 (0.9)
 Other 75 (3.6) 51 (5.1) 5 (2.4) 16 (4.2) 3 (2.7)

Percentages calculated among non-missing only, may not sum to 100 due to rounding

a

From hospital pathology reports;

b

From centralized pathology review;

c

Proportions calculated among non-missing

HHS Vulnerability Disclosure